79 related articles for article (PubMed ID: 25563557)
1. Rituximab-induced early and late signaling have opposite effects on dexamethasone-induced apoptosis in human follicular lymphoma cells.
Adem J; Ropponen A; Eeva J; Eray M; Pelkonen J; Nuutinen U
Leuk Lymphoma; 2015; 56(8):2448-57. PubMed ID: 25563557
[TBL] [Abstract][Full Text] [Related]
2. Differential Expression of Bcl-2 Family Proteins Determines the Sensitivity of Human Follicular Lymphoma Cells to Dexamethasone-mediated and Anti-BCR-mediated Apoptosis.
Adem J; Ropponen A; Eeva J; Eray M; Nuutinen U; Pelkonen J
J Immunother; 2016 Jan; 39(1):8-14. PubMed ID: 26641257
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of PI3-kinase-Akt pathway enhances dexamethasone-induced apoptosis in a human follicular lymphoma cell line.
Nuutinen U; Postila V; Mättö M; Eeva J; Ropponen A; Eray M; Riikonen P; Pelkonen J
Exp Cell Res; 2006 Feb; 312(3):322-30. PubMed ID: 16309671
[TBL] [Abstract][Full Text] [Related]
4. ERK1/2 has an essential role in B cell receptor- and CD40-induced signaling in an in vitro model of germinal center B cell selection.
Adem J; Hämäläinen A; Ropponen A; Eeva J; Eray M; Nuutinen U; Pelkonen J
Mol Immunol; 2015 Oct; 67(2 Pt B):240-7. PubMed ID: 26054744
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of the Raf-MEK1/2-ERK1/2 signaling pathway, Bcl-xL down-regulation, and chemosensitization of non-Hodgkin's lymphoma B cells by Rituximab.
Jazirehi AR; Vega MI; Chatterjee D; Goodglick L; Bonavida B
Cancer Res; 2004 Oct; 64(19):7117-26. PubMed ID: 15466208
[TBL] [Abstract][Full Text] [Related]
6. Rituximab and glucocorticoids: friends or foes? It is all about timing.
Ma S; Platanias LC
Leuk Lymphoma; 2015; 56(8):2237-8. PubMed ID: 25707289
[No Abstract] [Full Text] [Related]
7. Modulation of Glucocorticoid Resistance in Pediatric T-cell Acute Lymphoblastic Leukemia by Increasing BIM Expression with the PI3K/mTOR Inhibitor BEZ235.
Hall CP; Reynolds CP; Kang MH
Clin Cancer Res; 2016 Feb; 22(3):621-32. PubMed ID: 26080839
[TBL] [Abstract][Full Text] [Related]
8. Timing determines dexamethasone and rituximab induced synergistic cell death.
Adem J; Eray M; Eeva J; Nuutinen U; Pelkonen J
Mol Immunol; 2016 Jul; 75():200-2. PubMed ID: 27290654
[TBL] [Abstract][Full Text] [Related]
9. A novel BH3 mimetic efficiently induces apoptosis in melanoma cells through direct binding to anti-apoptotic Bcl-2 family proteins, including phosphorylated Mcl-1.
Liu Y; Xie M; Song T; Sheng H; Yu X; Zhang Z
Pigment Cell Melanoma Res; 2015 Mar; 28(2):161-70. PubMed ID: 25324174
[TBL] [Abstract][Full Text] [Related]
10. Dexamethasone-induced apoptosis and up-regulation of Bim is dependent on glycogen synthase kinase-3.
Nuutinen U; Ropponen A; Suoranta S; Eeva J; Eray M; Pellinen R; Wahlfors J; Pelkonen J
Leuk Res; 2009 Dec; 33(12):1714-7. PubMed ID: 19559478
[TBL] [Abstract][Full Text] [Related]
11. Phosphorylation of Bim-EL by Erk1/2 on serine 69 promotes its degradation via the proteasome pathway and regulates its proapoptotic function.
Luciano F; Jacquel A; Colosetti P; Herrant M; Cagnol S; Pages G; Auberger P
Oncogene; 2003 Oct; 22(43):6785-93. PubMed ID: 14555991
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of cyclic AMP/protein kinase A- and glucocorticoid-mediated apoptosis using S49 lymphoma cells as a model system.
Keshwani MM; Kanter JR; Ma Y; Wilderman A; Darshi M; Insel PA; Taylor SS
Proc Natl Acad Sci U S A; 2015 Oct; 112(41):12681-6. PubMed ID: 26417071
[TBL] [Abstract][Full Text] [Related]
13. Prometaphase arrest-dependent phosphorylation of Bcl-2 and Bim reduces the association of Bcl-2 with Bak or Bim, provoking Bak activation and mitochondrial apoptosis in nocodazole-treated Jurkat T cells.
Han CR; Jun do Y; Lee JY; Kim YH
Apoptosis; 2014 Jan; 19(1):224-40. PubMed ID: 24166139
[TBL] [Abstract][Full Text] [Related]
14. Cisplatin induced apoptosis of ovarian cancer A2780s cells by activation of ERK/p53/PUMA signals.
Song H; Wei M; Liu W; Shen S; Li J; Wang L
Histol Histopathol; 2018 Jan; 33(1):73-79. PubMed ID: 28287251
[TBL] [Abstract][Full Text] [Related]
15. Activation of Jun N-terminal kinase is a mediator of vincristine-induced apoptosis of melanoma cells.
Zhu BK; Wang P; Zhang XD; Jiang CC; Chen LH; Avery-Kiejda KA; Watts R; Hersey P
Anticancer Drugs; 2008 Feb; 19(2):189-200. PubMed ID: 18176116
[TBL] [Abstract][Full Text] [Related]
16. [Role of pro-apoptotic protein Bim in mouse thymocytes apoptosis induced by dexamethasone].
Zhao YN; Li Q; Yang K
Sichuan Da Xue Xue Bao Yi Xue Ban; 2007 Sep; 38(5):851-5. PubMed ID: 17953376
[TBL] [Abstract][Full Text] [Related]
17. CDK1, not ERK1/2 or ERK5, is required for mitotic phosphorylation of BIMEL.
Gilley R; Lochhead PA; Balmanno K; Oxley D; Clark J; Cook SJ
Cell Signal; 2012 Jan; 24(1):170-80. PubMed ID: 21924351
[TBL] [Abstract][Full Text] [Related]
18. MiR-92a mediates AZD6244 induced apoptosis and G1-phase arrest of lymphoma cells by targeting Bim.
Lv XB; Zhang X; Deng L; Jiang L; Meng W; Lu Z; Wang X
Cell Biol Int; 2014 Apr; 38(4):435-43. PubMed ID: 24375836
[TBL] [Abstract][Full Text] [Related]
19. Rituximab modifies the cisplatin-mitochondrial signaling pathway, resulting in apoptosis in cisplatin-resistant non-Hodgkin's lymphoma.
Alas S; Ng CP; Bonavida B
Clin Cancer Res; 2002 Mar; 8(3):836-45. PubMed ID: 11895917
[TBL] [Abstract][Full Text] [Related]
20. Bim is the key mediator of glucocorticoid-induced apoptosis and of its potentiation by rapamycin in human myeloma cells.
López-Royuela N; Balsas P; Galán-Malo P; Anel A; Marzo I; Naval J
Biochim Biophys Acta; 2010 Feb; 1803(2):311-22. PubMed ID: 19914305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
